94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/8e/2f/ca/8e2fcae1-17ae-b95e-b2d5-bb1b89a96281/mza_6105715200048338125.jpg/600x600bb.jpg

Healthspan

Michael Salzle

94 episodes

3 days ago

Become a Paid Subscriber: https://podcasters.spotify.com/pod/show/michael-salzle/subscribe Healthspan. The podcast that will add years to your life, and life to your years

Fitness

Health & Fitness

RSS

All content for Healthspan is the property of Michael Salzle and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Become a Paid Subscriber: https://podcasters.spotify.com/pod/show/michael-salzle/subscribe Healthspan. The podcast that will add years to your life, and life to your years

Fitness

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/5102232/5102232-1590559455956-ec4f01f2b0c47.jpg

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

Healthspan

11 minutes

1 year ago

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.